Henry Schein (NASDAQ:HSIC) Posts Earnings Results, Beats Estimates By $0.06 EPS

Henry Schein (NASDAQ:HSIC) released its quarterly earnings data on Tuesday. The company reported $1.22 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $1.16 by $0.06, Briefing.com reports. Henry Schein had a net margin of 2.82% and a return on equity of 13.19%. The company had revenue of $3.17 billion for the quarter, compared to analysts’ expectations of $3.24 billion. During the same quarter in the prior year, the firm earned $1.32 EPS. The business’s revenue was up .4% on a year-over-year basis. Henry Schein updated its FY 2024 guidance to 4.740-4.820 EPS.

Henry Schein Price Performance

NASDAQ:HSIC traded up $0.91 during trading hours on Wednesday, hitting $69.90. The stock had a trading volume of 759,511 shares, compared to its average volume of 1,345,775. The company has a 50 day simple moving average of $70.60 and a two-hundred day simple moving average of $69.78. The company has a debt-to-equity ratio of 0.46, a current ratio of 1.55 and a quick ratio of 0.90. Henry Schein has a one year low of $62.05 and a one year high of $82.63. The firm has a market capitalization of $8.86 billion, a price-to-earnings ratio of 25.94, a P/E/G ratio of 2.02 and a beta of 0.87.

Wall Street Analysts Forecast Growth

Several brokerages recently weighed in on HSIC. Barrington Research reaffirmed an “outperform” rating and issued a $82.00 price target on shares of Henry Schein in a research report on Friday, September 20th. Baird R W raised shares of Henry Schein from a “hold” rating to a “strong-buy” rating in a research report on Monday, July 22nd. Evercore ISI raised their price target on shares of Henry Schein from $70.00 to $74.00 and gave the company an “in-line” rating in a research report on Tuesday, October 8th. Robert W. Baird decreased their price objective on shares of Henry Schein from $92.00 to $82.00 and set an “outperform” rating for the company in a research note on Wednesday, August 7th. Finally, StockNews.com lowered shares of Henry Schein from a “hold” rating to a “sell” rating in a research note on Wednesday, October 30th. Two equities research analysts have rated the stock with a sell rating, five have assigned a hold rating, five have given a buy rating and one has assigned a strong buy rating to the stock. According to MarketBeat, Henry Schein has an average rating of “Hold” and an average price target of $77.50.

Insider Buying and Selling at Henry Schein

In other news, SVP Lorelei Mcglynn sold 21,035 shares of Henry Schein stock in a transaction on Friday, September 6th. The shares were sold at an average price of $69.30, for a total transaction of $1,457,725.50. Following the completion of the sale, the senior vice president now directly owns 71,833 shares of the company’s stock, valued at approximately $4,978,026.90. The trade was a 0.00 % decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is accessible through this link. Insiders own 1.14% of the company’s stock.

About Henry Schein

Henry Schein, Inc provides health care products and services to dental practitioners, laboratories, physician practices, and ambulatory surgery centers, government, institutional health care clinics, and other alternate care clinics worldwide. It operates through two segments, Health Care Distribution, and Technology and Value-Added Services.